CS logo
small CS logo
Hospital Universitario La Moraleja

Madrid, Spain
Hospital in Madrid
Av. de Francisco Pi y Margall, 81, 28050 Madrid

About Hospital Universitario La Moraleja


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Advanz Pharma
1
Averitas Pharma, Inc.
1
Consorci Sanitari de l'Alt Penedès i Garraf
1
Eisai Farmacêutica S.A.
1
Janssen Research & Development, LLC
1
University College, London
1
Total Rows: 7

Clinical Trials at Hospital Universitario La Moraleja


During the past decade, Hospital Universitario La Moraleja conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22000000111122110000000000110000Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 3 Study of Tanezumab for Chronic Low Back Pain
2015-08-18
2018-12-20
Completed
1,832
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
2015-10-28
2021-06-25
Completed
156
Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer
2012-06-01
2012-11-01
Completed
112
Collection of Data of Ceftobiprole Treated Patients: Comparison of Patients With and Without Certain Diseases
2020-03-30
2023-06-30
Recruiting
422
Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes - Clinical Trial
2019-11-26
2022-12-30
Unknown status
162
Prostate Imaging Using MRI +/- Contrast Enhancement
2022-04-05
2024-03-01
Recruiting
500
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
2021-06-30
2028-05-14
Recruiting
18,556
Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery
2021-07-13
2024-04-01
Recruiting
408

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital Universitario La Moraleja" #1 sponsor was "Pfizer" with 2 trials, followed by "Advanz Pharma" with 1 trials sponsored, "Averitas Pharma, Inc." with 1 trials sponsored, "Consorci Sanitari de l'Alt Penedès i Garraf" with 1 trials sponsored and "Eisai Farmacêutica S.A." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario La Moraleja" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "AMS Advanced Medical Services GmbH" with 1 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "European Regional Development Fund" with 1 trials as a collaborator and "Instituto de Salud Carlos III" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 2Pfizer: 2Advanz Pharma: 1Advanz Pharma: 1Averitas Pharma, Inc.: 1Averitas Pharma, Inc.: 1Consorci Sanitari del'Alt Penedès i Garraf: 1Consorci Sanitari del'Alt Penedès i Garraf: 1Eisai Farmacêutica S.A.: 1Eisai Farmacêutica S.A.: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1University College, London: 1University College, London: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2AMS Advanced MedicalServices GmbH: 1AMS Advanced MedicalServices GmbH: 1APCER Life Sciences: 1APCER Life Sciences: 1European RegionalDevelopment Fund: 1European RegionalDevelopment Fund: 1Instituto de Salud Carlos III: 1Instituto de Salud Carlos III: 1

Clinical Trials Conditions at Hospital Universitario La Moraleja


According to Clinical.Site data, the most researched conditions in "Hospital Universitario La Moraleja" are "Bone Metastasis" (1 trials), "Cancer Pain" (1 trials), "Hepatic Insufficiency" (1 trials), "Immunosuppression" (1 trials) and "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials). Many other conditions were trialed in "Hospital Universitario La Moraleja" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Universitario La Moraleja


Most popular intervention types in "Hospital Universitario La Moraleja" are "Drug" (3 trials), "Biological" (2 trials), "Diagnostic Test" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Biparametric MRI +/- prostate biopsy" (1 trials), "Ceftobiprole medocaril" (1 trials), "ExPEC9V" (1 trials), "Motor fluctuations diary" (1 trials) and "Multiparametric MRI +/- prostate biopsy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Universitario La Moraleja


The vast majority of trials in "Hospital Universitario La Moraleja" are 7 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Hospital Universitario La Moraleja


Currently, there are NaN active trials in "Hospital Universitario La Moraleja". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Universitario La Moraleja, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario La Moraleja, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusRecruiting: 4Recruiting: 4Completed: 3Completed: 3Unknown status: 1Unknown status: 1